David Flacks

David Mark Flacks currently works at AFT Pharmaceuticals Ltd., as Chairman from 2015, Suncorp New Zealand, as Chairman, Todd Corp Ltd, as Chairman from 2025, Asteron Life Ltd. (New Zealand), as Director, Vero Insurance New Zealand Ltd., as Director, Vero Liability Insurance Ltd., as Director, Todd Offshore Ltd., as Director, Flacks & Wong Ltd., as Director, Harmoney Share Sale Co. Ltd., as Director, COllaborative Advanced Genetic Technologies Ltd., as Director, Project Janszoon Trust Co. Ltd., as Director, Zero Invasive Predators Ltd., as Director, and Takeovers Panel (New Zealand), as Member.
Mr. Flacks also formerly worked at NZ Markets Disciplinary Tribunal, as Chairman, Upside Biotechnologies Ltd., as Chairman, NZX Ltd., as Chairman-Markets Disciplinary, ALPL Pty Ltd., as Director, Harmoney Corp.
Ltd., as Independent Director from 2021 to 2022, Carter Holt Harvey Ltd., as Secretary & General Counsel, and Bell Gully Services Ltd., as Partner.
Mr. Flacks received his undergraduate degree in 1975 from St. John's College, Cambridge.